Ionis Pharmaceuticals, Inc.
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
Last updated:
Abstract:
Provided herein are oligomeric compounds comprising a modified oligonucleotide and a conjugate group for modulating the amount or activity of a target nucleic acid in extra hepatic tissues and extra hepatic cells. Also provided herein are methods of modulating the amount or activity of an extra-hepatic nucleic acid target in a cell comprising contacting the cell with the oligomeric compound or antisense compound.
Status:
Application
Type:
Utility
Filling date:
26 Sep 2016
Issue date:
25 Feb 2021